Xcout Intel
SonoThera competitors & alternatives
The 12 closest competitors and alternatives to SonoThera among biotech companies — ranked by similarity to what SonoThera actually does, not by market-cap band.
Subscribe to see SonoThera’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About SonoThera
SonoThera, Inc. is a biotechnology company headquartered in South San Francisco, California, focused on developing genetic medicines and advancing the field of gene therapy.
SonoThera at a glance
SonoThera is a biotech company headquartered in United States. Its most recent funding round, Series B, raised $125M in June 2026. Xcout tracks 12 named people at SonoThera, including Carolyne Zimmermann (Chief Business Officer). Xcout recorded 7 job postings from SonoThera in the last 90 days.
SonoThera leadership
- Carolyne ZimmermannChief Business Officer
- Kenneth Greenbergco-founder, and chief executive officer
- Michael Davidsonco-founder
- Steve Feinsteinco-founder
- Carolyne ZimmermanExecutive Officer
- Kenneth GreenbergExecutive Officer
6 more named people on record for SonoThera, with roles, board committees and tenure — see the full roster →
SonoThera funding rounds
Every round on record:
| Date | Round | Amount | Investors |
|---|---|---|---|
| Series B | $125M | 13 named | |
| — | $60.8M | 14 named | |
| SEC Form D filing | $30.4M | — |
Who invested in each round, lead investors, valuations and the co-investor graph — open the full funding history →
Hiring at SonoThera
Xcout recorded 7 job postings from SonoThera in the last 90 days, from a hiring record Xcout has kept since June 2026.
The weekly hiring trend, the roles and locations behind it — see SonoThera's hiring signals →
Top 12 SonoThera competitors
Ranked by semantic similarity — how close each company is to SonoThera by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
BreezeBio is a biotechnology company headquartered in the South San Francisco area of California that develops precision genetic medicines.
Similar biotech company
Encoded Therapeutics is a biotechnology company headquartered in South San Francisco, California, dedicated to developing next-generation genetic medicines designed to address the root causes of genetic diseases.
Biotechnology
Neuron23 is a biotechnology company founded in 2018 that focuses on developing precision therapeutics for genetic diseases. Headquartered in South San Francisco, California, the company relies on a team of scientific experts and entrepreneurs.
Similar biotech company
Addition Therapeutics is a biotechnology research company based in South San Francisco, California. The firm is on a mission to fulfill the promise of genomic medicine for chronic and rare diseases, having emerged from stealth with significant funding.
Biotechnology
GeneTether, Inc., also known as Rize Oncology, is a biotechnology company headquartered in San Lorenzo, California, focused on developing proprietary gene-editing technologies and targeted oncology therapeutics.
Biotechnology
Averna Therapeutics is a biotechnology company developing genomic medicines utilizing RNA and lipid nanoparticle technologies. The company focuses on safe and efficient gene insertion and the treatment of rare genetic diseases through research and development teams located in Boston and Israel.
Similar biotech company
Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
Biotechnology
Gemma Labs Inc. (GEMMABio) is a biotechnology company that develops gene therapies for rare diseases using next-generation AAV technology. The company focuses on programs targeting motor neuron disorders, skeletal conditions, and cardiomyopathies to serve the rare disease community.
Similar biotech company
Adverum Biotechnologies is a clinical-stage biotechnology research company headquartered in Redwood City, California. The company focuses on developing novel gene therapies designed to redefine ocular care and treat severe eye diseases.
Similar biotech company
Frontier Medicines, Corp. is a precision medicine company focusing on drug development with offices in locations including South San Francisco, California, and Boston.
Biotechnology
Kelonia Therapeutics, Inc. is a clinical-stage biotech company headquartered in Boston, Massachusetts, focused on delivering genetic medicine for patients.
Biotechnology
Gordian Biotechnology is a biotechnology research company headquartered in South San Francisco, California. The company focuses on curing age-related diseases through in vivo target discovery and functional genomics platforms.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of SonoThera and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for SonoTheraand every competitor above — in one live dashboard.
Subscribe to Xcout Intel →